Search Results

You are looking at 1 - 2 of 2 items for

  • Author: Karthik Karuppaiah x
Clear All Modify Search
Karthik Karuppaiah Upper Limb Unit, Department of Orthopaedic Surgery, King’s College Hospital, London, UK

Search for other papers by Karthik Karuppaiah in
Google Scholar
PubMed
Close
and
Joydeep Sinha Upper Limb Unit, Department of Orthopaedic Surgery, King’s College Hospital, London, UK

Search for other papers by Joydeep Sinha in
Google Scholar
PubMed
Close

  • Injuries to the rotator cuff (RC) are common and could alter shoulder kinematics leading to arthritis. Synthetic and biological scaffolds are increasingly being used to bridge gaps, augment RC repair and enhance healing potential. Our review evaluates the clinical applications, safety and outcome following the use of scaffolds in massive RC repair.

  • A search was performed using EBSCO-Hosted Medline, CINAHL, Cochrane and PubMed using various combinations of the keywords ‘rotator cuff’, ‘scaffold’, ‘biological scaffold’, ‘massive rotator cuff tear’ ‘superior capsular reconstruction’ and ‘synthetic scaffold’ between 1966 and April 2018. The studies that were most relevant to the research question were selected. All articles relevant to the subject were retrieved, and their bibliographies hand searched.

  • Synthetic, biosynthetic and biological scaffolds are increasingly being used for the repair/reconstruction of the rotator cuff. Allografts and synthetic grafts have revealed more promising biomechanical and early clinical results than xenografts. The retear rates and local inflammatory reactions were alarmingly high in earlier xenografts. However, this trend has reduced considerably with newer versions. Synthetic patches have shown lower retear rates and better functional outcome than xenografts and control groups.

  • The use of scaffolds in the treatment of rotator cuff tear continues to progress. Analysis of the current literature supports the use of allografts and synthetic grafts in the repair of massive cuff tears in reducing the retear rate and to provide good functional outcome. Though earlier xenografts have been fraught with complications, results from newer ones are promising. Prospective randomized controlled trials from independent centres are needed before widespread use can be recommended.

Cite this article: EFORT Open Rev 2019;4:557-566. DOI: 10.1302/2058-5241.4.180040

Open access
John Edwin Kings College Hospital, London, UK

Search for other papers by John Edwin in
Google Scholar
PubMed
Close
,
Shahbaz Ahmed Pulvertaft Hand Centre, Royal Derby Hospital, Derby, UK

Search for other papers by Shahbaz Ahmed in
Google Scholar
PubMed
Close
,
Shobhit Verma Kings College Hospital, London, UK

Search for other papers by Shobhit Verma in
Google Scholar
PubMed
Close
,
Graham Tytherleigh-Strong Cambridge University Hospitals, UK

Search for other papers by Graham Tytherleigh-Strong in
Google Scholar
PubMed
Close
,
Karthik Karuppaiah Kings College Hospital, London, UK

Search for other papers by Karthik Karuppaiah in
Google Scholar
PubMed
Close
, and
Joydeep Sinha Kings College Hospital, London, UK

Search for other papers by Joydeep Sinha in
Google Scholar
PubMed
Close

  • The sternoclavicular joint (SCJ) is an integral part of the shoulder girdle that connects the upper limb to the axial skeleton.

  • Swelling of the SCJ is commonly due to trauma, degeneration, infections and other disease processes that affect synovial joints.

  • This review also focuses on uncommon conditions that could affect the SCJ, including SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome, Friedrich’s disease and Tietze syndrome.

  • The scope of this review is limited to the analysis of the current evidence on the various conditions affecting the SCJ and also to provide an algorithm to manage these conditions.

Cite this article: EFORT Open Rev 2018;3:471-484. DOI: 10.1302/2058-5241.3.170078

Open access